Profile | GDS5420 / 1558832_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 102.22 | 42 |
GSM1296119 | B_lesional_pre-dose | 104.5 | 41 |
GSM1296076 | C_lesional_pre-dose | 118.23 | 45 |
GSM1296092 | D_lesional_pre-dose | 73.41 | 39 |
GSM1296103 | E_lesional_pre-dose | 72.59 | 37 |
GSM1296078 | F_lesional_pre-dose | 82.82 | 40 |
GSM1296107 | G_lesional_pre-dose | 88.77 | 38 |
GSM1296109 | H_lesional_pre-dose | 134.18 | 44 |
GSM1296080 | I_lesional_pre-dose | 164.91 | 51 |
GSM1296090 | J_lesional_pre-dose | 55.32 | 34 |
GSM1296074 | K_lesional_pre-dose | 48.27 | 33 |
GSM1296111 | L_lesional_pre-dose | 64.36 | 32 |
GSM1296099 | M_lesional_pre-dose | 79.65 | 38 |
GSM1296086 | O_lesional_pre-dose | 59.94 | 35 |
GSM1296117 | P_lesional_pre-dose | 61.09 | 31 |
GSM1296113 | Q_lesional_pre-dose | 54.84 | 28 |
GSM1296096 | R_lesional_pre-dose | 83.04 | 39 |
GSM1296105 | S_lesional_pre-dose | 61.57 | 33 |
GSM1296098 | T_lesional_pre-dose | 163.16 | 49 |
GSM1296101 | U_lesional_pre-dose | 106.05 | 42 |
GSM1296121 | V_lesional_pre-dose | 99.58 | 40 |
GSM1296088 | W_lesional_pre-dose | 41.91 | 29 |
GSM1296082 | X_lesional_pre-dose | 65.01 | 37 |
GSM1296115 | Y_lesional_pre-dose | 85.31 | 37 |
GSM1296084 | Z_lesional_pre-dose | 169.8 | 50 |
GSM1296072 | B_lesional_day8 | 122.65 | 43 |
GSM1296069 | L_lesional_day8 | 70.99 | 33 |
GSM1296071 | P_lesional_day8 | 76.6 | 34 |
GSM1296070 | Y_lesional_day8 | 83.11 | 36 |
GSM1296073 | V_lesional_day8 | 81.12 | 37 |
GSM1296034 | A_lesional_day15 | 462.13 | 65 |
GSM1296041 | G_lesional_day15 | 58.93 | 31 |
GSM1296035 | R_lesional_day15 | 81.86 | 39 |
GSM1296038 | U_lesional_day15 | 84.82 | 39 |
GSM1296047 | B_lesional_day15 | 98.25 | 39 |
GSM1296039 | E_lesional_day15 | 68 | 36 |
GSM1296042 | H_lesional_day15 | 76.48 | 35 |
GSM1296043 | L_lesional_day15 | 77.97 | 34 |
GSM1296037 | M_lesional_day15 | 130.83 | 45 |
GSM1296046 | P_lesional_day15 | 70.75 | 33 |
GSM1296044 | Q_lesional_day15 | 94.58 | 38 |
GSM1296045 | Y_lesional_day15 | 58.82 | 29 |
GSM1296025 | C_lesional_day15 | 66.15 | 35 |
GSM1296033 | D_lesional_day15 | 77.89 | 38 |
GSM1296027 | I_lesional_day15 | 65.47 | 38 |
GSM1296032 | J_lesional_day15 | 107.52 | 42 |
GSM1296024 | K_lesional_day15 | 54.12 | 33 |
GSM1296031 | W_lesional_day15 | 94.38 | 40 |
GSM1296028 | X_lesional_day15 | 95.99 | 41 |
GSM1296029 | Z_lesional_day15 | 68.27 | 36 |
GSM1296026 | F_lesional_day15 | 66.4 | 35 |
GSM1296030 | O_lesional_day15 | 50.51 | 34 |
GSM1296040 | S_lesional_day15 | 123.41 | 44 |
GSM1296036 | T_lesional_day15 | 149.45 | 46 |
GSM1296048 | V_lesional_day15 | 106.86 | 41 |
GSM1296059 | A_lesional_day43 | 108.57 | 43 |
GSM1296066 | G_lesional_day43 | 69.93 | 33 |
GSM1296060 | R_lesional_day43 | 103.13 | 42 |
GSM1296063 | U_lesional_day43 | 57.19 | 32 |
GSM1296064 | E_lesional_day43 | 70.29 | 37 |
GSM1296067 | H_lesional_day43 | 103.37 | 39 |
GSM1296062 | M_lesional_day43 | 124.18 | 45 |
GSM1296068 | Q_lesional_day43 | 54.46 | 28 |
GSM1296050 | C_lesional_day43 | 79.13 | 37 |
GSM1296057 | D_lesional_day43 | 122.93 | 45 |
GSM1296052 | I_lesional_day43 | 63.83 | 37 |
GSM1296054 | J_lesional_day43 | 190.19 | 51 |
GSM1296049 | K_lesional_day43 | 106.02 | 43 |
GSM1296055 | W_lesional_day43 | 80.36 | 37 |
GSM1296053 | X_lesional_day43 | 160.71 | 49 |
GSM1296058 | Z_lesional_day43 | 103.64 | 43 |
GSM1296051 | F_lesional_day43 | 78.73 | 38 |
GSM1296056 | O_lesional_day43 | 92.64 | 42 |
GSM1296065 | S_lesional_day43 | 49.18 | 30 |
GSM1296061 | T_lesional_day43 | 188.61 | 51 |
GSM1296095 | A_non-lesional_pre-dose | 67.71 | 36 |
GSM1296120 | B_non-lesional_pre-dose | 87.3 | 37 |
GSM1296077 | C_non-lesional_pre-dose | 95.36 | 42 |
GSM1296093 | D_non-lesional_pre-dose | 248.65 | 55 |
GSM1296104 | E_non-lesional_pre-dose | 51.3 | 31 |
GSM1296079 | F_non-lesional_pre-dose | 125.58 | 46 |
GSM1296108 | G_non-lesional_pre-dose | 127.14 | 44 |
GSM1296110 | H_non-lesional_pre-dose | 125.72 | 42 |
GSM1296081 | I_non-lesional_pre-dose | 499.61 | 68 |
GSM1296091 | J_non-lesional_pre-dose | 67.43 | 36 |
GSM1296075 | K_non-lesional_pre-dose | 75.15 | 38 |
GSM1296112 | L_non-lesional_pre-dose | 84.7 | 35 |
GSM1296100 | M_non-lesional_pre-dose | 223.8 | 54 |
GSM1296087 | O_non-lesional_pre-dose | 92.44 | 43 |
GSM1296118 | P_non-lesional_pre-dose | 83.1 | 35 |
GSM1296114 | Q_non-lesional_pre-dose | 93.42 | 37 |
GSM1296097 | R_non-lesional_pre-dose | 61.03 | 34 |
GSM1296106 | S_non-lesional_pre-dose | 92.71 | 39 |
GSM1296102 | U_non-lesional_pre-dose | 156.2 | 47 |
GSM1296122 | V_non-lesional_pre-dose | 134.73 | 44 |
GSM1296089 | W_non-lesional_pre-dose | 95.57 | 39 |
GSM1296083 | X_non-lesional_pre-dose | 322.4 | 60 |
GSM1296116 | Y_non-lesional_pre-dose | 49.11 | 26 |
GSM1296085 | Z_non-lesional_pre-dose | 87.06 | 39 |